반응식
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([S:9]([CH3:11])=O)=[C:6]([CH:8]=1)[NH2:7].[Cl:12][C:13]1[CH:14]=[C:15]([S:20](Cl)(=[O:22])=[O:21])[CH:16]=[CH:17][C:18]=1[Cl:19]>>[Cl:12][C:13]1[CH:14]=[C:15]([S:20]([NH:7][C:6]2[CH:8]=[C:2]([Cl:1])[CH:3]=[CH:4][C:5]=2[S:9][CH3:11])(=[O:21])=[O:22])[CH:16]=[CH:17][C:18]=1[Cl:19]참가 물질
3
실험 절차
Following General Procedure B, the title compound (52 mg, 21%) was prepared from 5-chloro-2-(methylsulfinyl)aniline (Intermediate 2) (120 mg, 0.635 mmol) and 3,4-dichlorobenzene-1-sulfonyl chloride (156 mg, 0.635 mmol).
출처 및 근거
- ORD 기록
- ord-a6728c0286504da2934217103634da1f
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08822530B2
연결된 노트
불러오는 중…